Kukje Pharm

Kukje Pharm is a prominent South Korean pharmaceutical company established in 1959, specializing in the development and manufacturing of diverse therapeutic agents. The company is a recognized leader in the ophthalmic market, providing a comprehensive range of treatments for conditions such as glaucoma, dry eye syndrome, and retinal diseases. In addition to its ophthalmic focus, Kukje Pharm maintains a strong presence in antibiotics, cardiovascular medications, and digestive health products. The firm operates a state-of-the-art, GMP-certified manufacturing facility in Ansan and is publicly traded on the Korea Stock Exchange. Through its subsidiary KJ Care, the company also provides medical devices and healthcare services, demonstrating a broad commitment to the healthcare sector.